Tilray, Inc. Series 2 Aktie News

The cannabis industry is in another pivotal time where consistent changes are being made. Laws and regulations have been passed across the country that have aided in the further development of industry. For most marijuana stock investors, this is the area where shareholders tend to focus. Investors know that a company is doing well, or is working towards a significant goal, which can all lead t...

BRECKENRIDGE, Colo., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Breckenridge Distillery,  an award-winning craft distillery and spirits brand owned by  Tilray Brands, Inc.  (NASDAQ: TLRY; TSX: TLRY), has announced appointment of Romano Beverage, a respected partner, to manage distribution responsibilities within the state.

DENSBORN, Germany, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Tilray Pharma the pharmaceutical division of Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), today announced that CC Pharma, its European pharmaceutical distribution business, has been named a  TOP 100 Innovator in Germany , one of the country's most respected and independent recognitions for innovation among small and mid-sized enterprises. C...

Tilray Brands stock price continued its strong downward trend, reaching its lowest level since December 9 last year. It has crashed by over 68% from its highest level in October last year.

Gear up for game day, Sunday, February 8, 2026, with ultimate fan experiences, beer, wings, whiskey, and more at SweetWater Brewing Co., Montauk Brewing Co., Breckenridge Brewery, Blue Point Brewing Co., 10 Barrel Brewing Co., Hop Valley Brewing Co., Terrapin Beer Co., and Atwater Brewery Gear up for game day, Sunday, February 8, 2026, with ultimate fan experiences, beer, wings, whiskey, and mo...

ATHENS, Ga., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Terrapin Beer Co. (Terrapin), a craft beer brand by Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), today announced a comprehensive brand refresh.

Tilray is strategically positioned to benefit from U.S. cannabis reform, leveraging its diversified international and U.S. beverage operations. International medical cannabis, especially in Europe, drives TLRY's growth and margin stability, with Germany and Italy as key markets. Profitability hinges on sustained double-digit international growth, normalized interest and restructuring costs, and...

The Canadian cannabis sector continues evolving as companies adapt to shifting consumer demand and global regulations. While volatility remains common, long-term opportunities still attract patient investors. Moreover, potential U.S. federal reform continues to influence sentiment across Canadian operators. Many Canadian companies maintain indirect exposure to the U.S. cannabis market through b...